15 The first study that investigated Viaskinincow's milk allergy was a pilot study to determine short-term safety and tolerability, and demonstrated that milk EPIT was well tolerated, with a nonsignificant trend toward improvement in the cumulative tolerated dose of milk. 16 This prompted further investigation with a phase I/II study that evaluated Viaskin milk at 150-, 300-, and 500- μ g doses (Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy (MILES), NCT02223182 ), 17 which is ongoing.
1
—
—